Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine [Yahoo! Finance]
Tempus AI, Inc. - Class A (TEM)
Company Research
Source: Yahoo! Finance
partnership with Merck to fast-track the development of AI-driven precision medicine and support the pharma-maker's oncology portfolio and other therapeutic offerings. As part of the agreement, Merck will leverage Tempus AI, Inc. (NASDAQ:TEM)'s de-identified data and Lens Platform and Workspaces technologies to generate new discoveries and accelerate the development and effective use of candidate therapies on a large scale. In other news, on February 25, JPMorgan analyst Casey Woodring slashed the stock's price target to $60 from $80, with a Neutral rating, following the company's Q4 earnings call a day prior. Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine Photo from Iovance Biotherapeutics website According to TipRanks, the firm cited Tempus AI, Inc.'s (NASDAQ:TEM) ‘clouded visibility' on data upside and a revision to its outlook for Ambry as the reason behind the adjustment. As of the close of business on March 4, the
Show less
Read more
Impact Snapshot
Event Time:
TEM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEM alerts
High impacting Tempus AI, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
TEM
News
- H.C. Wainwright Raises Tempus AI (TEM) Price Target to $95 [Yahoo! Finance]Yahoo! Finance
- Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data RegistriesBusiness Wire
- Cathie Wood buys $2 million of tumbling AI stock [Yahoo! Finance]Yahoo! Finance
- Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable FindingsBusiness Wire
- Tempus AI (TEM) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $75.00 price target on the stock.MarketBeat
TEM
Earnings
- 2/24/26 - Beat
TEM
Sec Filings
- 3/6/26 - Form SCHEDULE
- 3/4/26 - Form 4
- 3/4/26 - Form 4
- TEM's page on the SEC website